LimmaTech Biologics AG
|Category:||Emerging Biotech Company|
|Date:||April 24, 2023|
|Speaker:||Patricia Martin, PhD, Managing Director and Vice President Clinical and Regulatory Affairs|
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We apply our deep expertise in engineering complex carbohydrate molecules to develop next-generation vaccines to prevent life-threatening diseases. Our proprietary vaccine pipeline is focused on halting the increasing threat of global infections due to antimicrobial resistance (AMR) and sexually transmitted diseases. We also develop vaccines with our partner, GSK.